Special Issue "Mechanisms of Bacterial Antibiotic Resistance and Interventions to Prevent Their Spread"
Deadline for manuscript submissions: 30 November 2021.
Interests: bacterial antibiotic resistance: epidemiology, mechanisms, and interventions; tuberculosis: epidemiology and drug resistance; global health
Antimicrobial resistance (AMR), including bacterial antibiotic resistance, remains a global public health threat, causing over 700,000 deaths each year. In the November 2020 report published by the Wellcome Trust, it is clear that the trajectory and success of our response to AMR will depend on actions and policies of the next few years.Whereas the COVID-19 pandemic has surely slowed and diverted resources away from AMR research and control, our response to it has also shown new possibilities for innovation and collaboration that can potentially be employed for other causes, such as AMR.
In this Special Issue, we welcome the sharing of new insights into bacterial (including Mycobacterium tuberculosis) antibiotic resistance and control. We look forward to contributions in the form of original research or systematic reviews in the following areas:
- Mechanisms of bacterial antibiotic resistance, in particular focusing on carbapenem and polymyxin resistance, as well as resistance to new antibiotics and new anti-tuberculosis drugs
- Appropriate prescribing of antibiotics, particularly in the community setting
- Novel infection prevention methods for preventing the spread of drug-resistant bacteria in the hospital setting and community setting
- The role of the human and environmental microbiome on bacterial antibiotic resistance
Please contact us directly for other topics not listed above.
Dr. Li Yang HSU
Dr. Rick Twee-Hee ONG
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bacterial antibiotic resistance
- antibiotic stewardship
- drug-resistant tuberculosis
- infection prevention
- novel antibiotics